Grant: Discovery Grants Program - Individual
Université Laval
$40,101.00
The papaya mosaic virus platform; an innovative tool in nanotechnology
FY 2012-13
Summary
Self-assembly of the papaya mosaic virus (PapMV) coat protein (CP) into a highly ordered and crystalline flexible rod is a complex process that involves several conformational changes and interacting domains within the CP subunits.
We propose to elucidate the mechanism of self assembly of the coat protein of this virus.
The long term objectives of this research program are: 1) to reinforce our understanding of the self-assembly process of the PapMV CP; 2) to unravel the mechanism of virus self-assembly in planta and; 3) to translate our understanding of the platform into topical antimicrobial applications for commercial production by specific engineering of the PapMV CP.
The development of anti-microbial molecule could be used as an alternative to antibiotics. The novel nanoparticle could be used for topical use to improve (wound) healing by decreasing the risk of infectious contamination. Due to their increased stability, antimicrobial NLPs could probably be stored for long periods at room temperature and still provide long lasting anti-bacterial activity. The PapMV platform is a good example of a made-in-Canada nanoparticle that has potentially useful commercial antimicrobial applications that fulfill an unmet need for the Canadian and world populations seeking alternatives to antibiotics.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
227041-2008
Name nom
Leclerc, Denis
Department département
Microbiologie-infectiologie et d'immunologie
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2008
Award amount
40101
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
5
Nb partie
8
Application title
The papaya mosaic virus platform; an innovative tool in nanotechnology
Keyword
NSERC
Application summary
Self-assembly of the papaya mosaic virus (PapMV) coat protein (CP) into a highly ordered and crystalline flexible rod is a complex process that involves several conformational changes and interacting domains within the CP subunits.
We propose to elucidate the mechanism of self assembly of the coat protein of this virus.
The long term objectives of this research program are: 1) to reinforce our understanding of the self-assembly process of the PapMV CP; 2) to unravel the mechanism of virus self-assembly in planta and; 3) to translate our understanding of the platform into topical antimicrobial applications for commercial production by specific engineering of the PapMV CP.
The development of anti-microbial molecule could be used as an alternative to antibiotics. The novel nanoparticle could be used for topical use to improve (wound) healing by decreasing the risk of infectious contamination. Due to their increased stability, antimicrobial NLPs could probably be stored for long periods at room temperature and still provide long lasting anti-bacterial activity. The PapMV platform is a good example of a made-in-Canada nanoparticle that has potentially useful commercial antimicrobial applications that fulfill an unmet need for the Canadian and world populations seeking alternatives to antibiotics.